AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18819444 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacoepidemiology studies
Number of subjects: 0
Study 16671417 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic brain injury patients with significant brain swelling
Number of subjects: 53
Study 16671417 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic brain injury patients without swelling
Number of subjects: 53
Study 16671417 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 53
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride
Number of subjects: 80
Study 12791448 — intervention group
Group type: COMPARATOR
Intervention: Placebo (9% NaCl)
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine vs Dexamethasone
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine vs Lidocaine
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone vs Lidocaine
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine, Dexamethasone, Lidocaine vs Placebo
Number of subjects: 80
Study 12791448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine, Dexamethasone, Lidocaine
Number of subjects: 80
Study 10748784 — intervention group
Group type: EXPERIMENTAL
Intervention: Various management options for menorrhagia
Number of subjects: 0
Study 9297773 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser soldering technique (LTW)
Number of subjects: 37
Study 8383270 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana smoking
Number of subjects: 0
Study 3521103 — intervention group
Group type: COMPARATOR
Intervention: 400 mg cimetidine b.i.d.
Number of subjects: 86
Study 3521103 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg cimetidine nocte
Number of subjects: 86
Study 30260984 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% price discount on healthy food and beverages
Number of subjects: 0
Study 30260984 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% price discount on healthy food and beverages with consumer education
Number of subjects: 0
Study 26832653 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin Sequential Therapy (LS): lansoprazole and amoxicillin for the first 5 days, followed by lansoprazole, levofloxacin, and metronidazole for another 5 days
Number of subjects: 600
Study 26832653 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin Triple Therapy (LT): lansoprazole, amoxicillin, and levofloxacin for 10 days
Number of subjects: 600
Study 23831184 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta-rhythm transcranial alternating current stimulation (tACS) over the dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study 23831184 — intervention group
Group type: COMPARATOR
Intervention: Sham non-active stimulation
Number of subjects: 0
Study 21835900 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (30 mg/kg in the cardiopulmonary bypass prime, 500 mg IV bolus following the final circulatory arrest, and 250 mg IV bolus 36 h after surgery)
Number of subjects: 98
Study 21835900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 21835900 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 98
Study 20627877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl infusion (bolus dose of 1 microg kg(‐1) followed by continuous infusion of 0.5 microg kg(‐1) h(‐1))
Number of subjects: 150
Study 20627877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl infusion (bolus dose of 2 microg kg(‐1) followed by continuous infusion of 1 microg kg(‐1) h(‐1))
Number of subjects: 150
Study 20627877 — intervention group
Group type: COMPARATOR
Intervention: Control group (vehicle only)
Number of subjects: 150
Study 19305031 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil based emulsion (ClinOleic)
Number of subjects: 44
Study 19305031 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil based emulsion (Ivelip)
Number of subjects: 44
Study 19305031 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Olive oil and Soybean oil)
Number of subjects: 44
Study 16164393 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐α antagonists (infliximab, etanercept, adalimumab)
Number of subjects: 0
Study 16164393 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening procedures for potential recipients of TNF‐α antagonists
Number of subjects: 0
Study 11322864 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular radiation (brachytherapy)
Number of subjects: 150000
Study 11322864 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged antiplatelet therapy
Number of subjects: 150000
Study 11322864 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in the number of new stents placed at the time of radiation
Number of subjects: 150000
Study 9730394 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP-BAND with hiatus hernia
Number of subjects: 50
Study 9730394 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP-BAND with motility disorder
Number of subjects: 50
Study 9730394 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP-BAND with both hiatus hernia and motility disorder
Number of subjects: 50
Study 11271240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (CyA) and Nifedipine
Number of subjects: 0
Study 11271240 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin (CyA)
Number of subjects: 0
Study 2648788 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg twice daily for 1 week, followed by 40 mg twice daily for 3 weeks)
Number of subjects: 221
Study 2648788 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 221
Study 2648788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 19674225 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-day university-based training course
Number of subjects: 42
Study 19674225 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for training (Control)
Number of subjects: 42
Study 367501 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochlorite-sterilised vessels
Number of subjects: 0
Study 367501 — intervention group
Group type: EXPERIMENTAL
Intervention: Holder pasteurisation
Number of subjects: 0
Study 367501 — intervention group
Group type: COMPARATOR
Intervention: Untreated milk
Number of subjects: 0
Study 30663824 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine
Number of subjects: 40
Study 30663824 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 29932581 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional mode of ventilation
Number of subjects: 37
Study 29932581 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ventilation mode with inversion of the respiratory cycle and high-level application of PEEP titration
Number of subjects: 37
Study 26049551 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 33
Study 26049551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 23410616 — intervention group
Group type: EXPERIMENTAL
Intervention: Current cannabis use (past 30 days)
Number of subjects: 0
Study 23410616 — intervention group
Group type: EXPERIMENTAL
Intervention: Current and recent past cannabis use
Number of subjects: 0
Study 23410616 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent past cannabis use (not in past 30 days)
Number of subjects: 0
Study 21435093 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day sequential therapy (esomeprazole and amoxicillin for 7 days followed by esomeprazole, clarithromycin, and metronidazole for 7 days)
Number of subjects: 123
Study 21435093 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day sequential therapy
Number of subjects: 123
Study 19485840 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care testing (PoCT)
Number of subjects: 4968
Study 19485840 — intervention group
Group type: COMPARATOR
Intervention: Pathology laboratory testing
Number of subjects: 4968
Study 17595593 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose transdermal estradiol (E2)/norethisterone acetate (NETA) patches (Estalis 25/125)
Number of subjects: 0
Study 17595593 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral E2/NETA (Activelle)
Number of subjects: 0
Study 15168217 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 10
Study 15168217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11435839 — intervention group
Group type: EXPERIMENTAL
Intervention: Prelubricated nonhydrophilic catheter
Number of subjects: 18
Study 11435839 — intervention group
Group type: COMPARATOR
Intervention: Nélaton catheter
Number of subjects: 18
Study 9544873 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of trandolapril
Number of subjects: 631
Study 9544873 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg of verapamil SR
Number of subjects: 631
Study 9544873 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 4 mg of trandolapril and 240 mg of verapamil SR
Number of subjects: 631
Study 9544873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 631
Study 8291491 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride gel (SnF2) used twice daily for 18 months
Number of subjects: 62
Study 8291491 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoride toothpaste with toothbrushing (control)
Number of subjects: 62
Study 2566736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline plus polidocanol 1%
Number of subjects: 140
Study 2566736 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline plus YAG laser therapy
Number of subjects: 140
Study 2566736 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline alone
Number of subjects: 140
Study 2566736 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 140
Study 30678679 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient psychiatric treatment for clinical mental disorder
Number of subjects: 586
Study 30678679 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive cognitive behavioural therapy for subclinical conditions
Number of subjects: 586
Study 30678679 — intervention group
Group type: COMPARATOR
Intervention: Composed control group
Number of subjects: 586
Study 27966239 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD codes
Number of subjects: 427
Study 27966239 — intervention group
Group type: EXPERIMENTAL
Intervention: DRG codes
Number of subjects: 427
Study 25852125 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine (LAM, n=82)
Number of subjects: 168
Study 25852125 — intervention group
Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine (TDF/FTC, n=86)
Number of subjects: 168
Study 25852125 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine (LAM)
Number of subjects: 168
Study 25852125 — intervention group
Group type: EXPERIMENTAL
Intervention: tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 168
Study 23866798 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 280
Study 23866798 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention
Number of subjects: 280
Study 21826713 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand neuromodulation
Number of subjects: 16
Study 21826713 — intervention group
Group type: COMPARATOR
Intervention: Continuous neuromodulation (Control)
Number of subjects: 16
Study 19687086 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified carpal tunnel syndrome questionnaire (Boston Carpal Tunnel Questionnaire, BCTQ)
Number of subjects: 76
Study 17644487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion (CCF) exercise
Number of subjects: 48
Study 17644487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical flexion (CF) exercise
Number of subjects: 48
Study 15325681 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (Gln) supplementation
Number of subjects: 20
Study 15325681 — intervention group
Group type: COMPARATOR
Intervention: Placebo amino acid
Number of subjects: 20
Study 11159567 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodermal testing using the Vegatest device
Number of subjects: 30
Study 9674373 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially operational ATM mock-up with natural speech output, different function menus, and different key arrangements
Number of subjects: 15
Study 9674373 — intervention group
Group type: COMPARATOR
Intervention: Partially operational ATM mock-up
Number of subjects: 15
Study 7493120 — intervention group
Group type: EXPERIMENTAL
Intervention: Transsclerally fixed anterior chamber lenses with S-shaped haptics and multipoint support
Number of subjects: 0
Study 7493120 — intervention group
Group type: COMPARATOR
Intervention: C-loop posterior chamber lens
Number of subjects: 0
Study 2692227 — intervention group
Group type: EXPERIMENTAL
Intervention: Maloprim (pyrimethamine + dapsone)
Number of subjects: 0
Study 2692227 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil (Lapudrine)
Number of subjects: 0
Study 2692227 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 0
Study 4653876 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified water recovery test
Number of subjects: 50
Study 4653876 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 50
Study 31789201 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekend work (nonstandard schedules) for mothers
Number of subjects: 21766
Study 31789201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonstandard hours for women without children
Number of subjects: 21766
Study 31789201 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal nonstandard hour work
Number of subjects: 21766
Study 31789201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonstandard days and hours for men without children
Number of subjects: 21766
Study 30925499 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 106
Study 30925499 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 106
Study 28539646 — intervention group
Group type: EXPERIMENTAL
Intervention: High Acetate (HA)
Number of subjects: 12
Study 28539646 — intervention group
Group type: EXPERIMENTAL
Intervention: High Propionate (HP)
Number of subjects: 12
Study 28539646 — intervention group
Group type: EXPERIMENTAL
Intervention: High Butyrate (HB)
Number of subjects: 12
Study 28539646 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 23971514 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored advice regarding exposure to daylight, optimizing sleep, physical activity, and nutrition delivered via a smartphone application and website.
Number of subjects: 0
Study 23971514 — intervention group
Group type: COMPARATOR
Intervention: Standard available information (Control group).
Number of subjects: 0
Study 23971514 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored advice regarding exposure to daylight, optimizing sleep, physical activity, and nutrition.
Number of subjects: 0
Study 21299387 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion and cervical pull headgear (RME/HG)
Number of subjects: 64
Study 21299387 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pull headgear (HG)
Number of subjects: 64
Study 21299387 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group (CG)
Number of subjects: 64
Study 21299387 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 64
Study 19938903 — intervention group
Group type: EXPERIMENTAL
Intervention: Vernakalant hydrochloride
Number of subjects: 0
Study 16715781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine tablets (test)
Number of subjects: 24
Study 16715781 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine capsules (reference)
Number of subjects: 24
Study 14982197 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0
Study 14982197 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0
Study 11753061 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with bupivacaine
Number of subjects: 15
Study 11753061 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with lidocaine
Number of subjects: 15
Study 11753061 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 15
Study 11753061 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block of injured leg only
Number of subjects: 15
Study 11753061 — intervention group
Group type: COMPARATOR
Intervention: Overall (all groups)
Number of subjects: 15
Study 9252131 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (8 mg, ingested 13 and 4 hours before the meal)
Number of subjects: 8
Study 8375421 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 50 mg twice daily
Number of subjects: 461
Study 8375421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 461
Study 3752983 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (2 g intravenously every 6 hours for 21 doses)
Number of subjects: 10
Study 3752983 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (control group)
Number of subjects: 10
Study 31881985 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebanese Insomnia Scale (LIS-18)
Number of subjects: 789
Study 29707866 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzagliatin 75 mg BID
Number of subjects: 24
Study 29707866 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzagliatin 75 mg QD
Number of subjects: 24
Study 26984807 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate administered once a night at a dose of 2 mg/kg/day
Number of subjects: 85
Study 26984807 — intervention group
Group type: COMPARATOR
Intervention: Topiramate administered twice a day at a dose of 4 mg/kg/day
Number of subjects: 85
Study 25280957 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide plus calorie-restricted diet
Number of subjects: 50
Study 25280957 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus calorie-restricted diet
Number of subjects: 50
Study 22994021 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and bed rest
Number of subjects: 188
Study 20103825 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality RCTs
Number of subjects: 250
Study 20103825 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-quality RCTs
Number of subjects: 250
Study 20103825 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-quality RCTs
Number of subjects: 250
Study 20103825 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality RCTs supporting claims
Number of subjects: 250
Study 20103825 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality RCTs not sponsored by pharmaceutical companies
Number of subjects: 250
Study 17578905 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil and midazolam sedation
Number of subjects: 26
Study 17578905 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil pharmacokinetics
Number of subjects: 26
Study 15760531 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with cardiopulmonary bypass (CCABG)
Number of subjects: 60
Study 15760531 — intervention group
Group type: COMPARATOR
Intervention: CABG without cardiopulmonary bypass (OPCABG)
Number of subjects: 60
Study 12029630 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg losartan
Number of subjects: 19
Study 12029630 — intervention group
Group type: COMPARATOR
Intervention: Control (no losartan)
Number of subjects: 19
Study 10220630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol 5 mg x 3 plus 5 mg morphine
Number of subjects: 262
Study 10220630 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo plus 5 mg morphine
Number of subjects: 262
Study 7778826 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine or 6-mercaptopurine therapy
Number of subjects: 9
Study 7778826 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine therapy
Number of subjects: 9
Study 7778826 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of therapy for at least 17 weeks
Number of subjects: 9
Study 7778826 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of azathioprine
Number of subjects: 9
Study 7778826 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased cumulative dose
Number of subjects: 9
Study 1401645 — intervention group
Group type: EXPERIMENTAL
Intervention: Solenopsis invicta (Sol i) fire ant venom (IFAV)
Number of subjects: 66
Study 1401645 — intervention group
Group type: COMPARATOR
Intervention: Imported fire ant whole body extracts (IFA WBEs)
Number of subjects: 66
Study 1401645 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioallergosorbent test (RAST) to IFAV and both IFA WBEs
Number of subjects: 66
Study 1401645 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin testing with IFAV
Number of subjects: 66
Study 1401645 — intervention group
Group type: COMPARATOR
Intervention: Skin testing with IFA WBE
Number of subjects: 66
Study 6496202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarette
Number of subjects: 10
Study 6496202 — intervention group
Group type: COMPARATOR
Intervention: Zero-nicotine cigarette
Number of subjects: 10
Study 31862032 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated driving in a conversation robot's presence
Number of subjects: 126
Study 31862032 — intervention group
Group type: COMPARATOR
Intervention: Simulated driving alone
Number of subjects: 126
Study 28978975 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year tailored multi-component physical activity intervention program
Number of subjects: 9858
Study 28978975 — intervention group
Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 9858
Study 27711088 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts (1 tablet per day for 3 months)
Number of subjects: 0